tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood glucose control by artificial pancreas

Documenti analoghi

• Investigation of insulin clearance in septic patients with glucose intolerance: analysis under strict blood glucose control by means of artificial pancreas
  di: Hoshino, M, et al.
  Pubblicazione: (2001)
• Close relationship of PAI-1 (plasminogen activator inhibitor-1) with multiple organ dysfunction syndrome and abnormal glucose metabolism investigated by means of artificial pancreas
  di: Hoshino, M, et al.
  Pubblicazione: (1998)
• Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
  di: Hoshino, Masami, et al.
  Pubblicazione: (2001)
• Investigation of the factors which influence insulin sensitivity in septic patients with glucose intolerance: analysis with glucose clamp method by means of artificial pancreas
  di: Hoshino, M, et al.
  Pubblicazione: (2002)
• Hypercoagulability indicated by elevated blood TFPI (tissue factor pathway inhibitor) levels is closely related to severity of septic patients with glucose intolerance
  di: Hoshino, M, et al.
  Pubblicazione: (2000)